Mapping Interaction Sites on Human Chemokine Receptors by Deep Mutational Scanning

Jeremiah D Heredia1, Jihye Park1, Riley J Brubaker1

  • 1Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL 61801.

Insights

This study maps functional sites on chemokine receptors CXCR4 and CCR5 using deep mutational scanning. Novel mutations were found that enhance receptor activity and ligand binding, offering new insights into HIV-1 entry and WBC trafficking.

Area of Science:

  • Molecular Biology
  • Immunology
  • Virology

Background:

  • Chemokine receptors CXCR4 and CCR5 are crucial for white blood cell (WBC) trafficking and serve as entry points for HIV-1 infection via the envelope glycoprotein gp120.
  • Understanding the precise interactions between these receptors and their ligands is vital for developing therapeutic strategies against viral infections and inflammatory diseases.

Purpose of the Study:

  • To comprehensively map the sequence-activity landscapes of CXCR4 and CCR5, defining residues critical for surface expression, ligand binding, and G protein signaling.
  • To identify novel mutations that enhance receptor activity and ligand interactions, particularly in the context of HIV-1 binding.

Main Methods:

  • Utilized deep mutational scanning of large, comprehensive human CXCR4 and CCR5 single amino acid substitution libraries (∼7000 substitutions each).
  • Employed deep sequencing to analyze library sorting results for surface expression, antibody binding (HIV-1 blocking), and chemokine interactions (CXCL12 for CXCR4, gp120 for CCR5).
  • Correlated mutational effects with known functional sites, including G protein-coupling domains and ligand-binding pockets.

Main Results:

  • Deep mutational scanning successfully identified conserved residues at known interaction sites, validating the method for mapping functional hotspots in G protein-coupled receptors.
  • CXCR4 interactions with CXCL12 involve residues extending into the binding cavity, with distal mutations found to enhance chemokine recognition and ligand binding without compromising signaling.
  • CCR5 interactions with HIV-1 gp120 involve a broader surface compared to CXCR4-CXCL12, with acidic substitutions in the N-terminus and extracellular loops enhancing gp120 binding.

Conclusions:

  • Comprehensive mutational scanning is a powerful approach to define functional interaction sites on chemokine receptors.
  • Novel mutations enhancing CXCR4 and CCR5 activity and ligand binding were identified, providing potential targets for therapeutic intervention.
  • The study elucidates distinct interaction mechanisms for CXCR4 and CCR5 with their respective ligands and HIV-1, informing future drug design.

Related Concept Videos

Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.2K
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.2K
Mutations01:39

Mutations

Overview
94.6K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.6K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
40.0K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
5.1K